Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 1495Recruiting 418Terminated 390Unknown 361Active not recruiting 286Withdrawn 129Not yet recruiting 86Suspended 15No longer available 3Enrolling by invitation 2Temporarily not available 1Approved for marketing 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Recurrence 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cisplatin 9Specimen Handling 7Educational Status 7Standard of Care 6Interviews as Topic 6Drug Therapy 6Carboplatin 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Observation 4Lenalidomide 4Fluorouracil 4Fluorodeoxyglucose F18 4Dexamethasone 4pembrolizumab 3lenvatinib 3camrelizumab 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Gemcitabine 3Exercise 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Cyclophosphamide × Clear all
NCT07258680 2025-12-02

BrEto-TCL

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Enrolling by invitation
114 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT07168486 2025-09-11

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

University of Maryland, Baltimore

Phase 1 Enrolling by invitation
15 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡